Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals

Journal of Korean Medical Science

Volumn 26, Issue 7, 2011, Pages 893-899

  Kang, Hee Joon ^a   Youn, Yeo Kyu ^b   Hong, Mi Kyoung ^a   Kim, Lee Su ^a  

^a Hallym University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

CD97; F9 embryonal carcinoma cell; Phytochemical; Polyphenols; Redifferentiation; Sodium iodine symporter; Thyroid neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CD97 PROTEIN, HUMAN; COTRANSPORTER; FLAVONOID; GENISTEIN; KAEMPFEROL; KAEMPFEROL DERIVATIVE; LEUKOCYTE ANTIGEN; PHENOL DERIVATIVE; POLYPHENOLS; QUERCETIN; RESORCINOL; RESORCINOL DERIVATIVE; RESVERATROL; SODIUM IODIDE SYMPORTER; STILBENE DERIVATIVE;

ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; THYROID TUMOR; TUMOR CELL LINE;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; KAEMPFEROLS; MODELS, BIOLOGICAL; PHENOLS; QUERCETIN; RESORCINOLS; STILBENES; SYMPORTERS; THYROID NEOPLASMS;

EID: 79960128163     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.7.893     Document Type: Article

References (30)

1. Park JW, Clark OH. Redifferentiation therapy for thyroid cancer. Surg Clin North Am 2004; 84: 921-43.
2. Schmutzler C, Koehrle J. Innovative strategies for treatment of thyroid cancer. Eur J Endocrinol 2000; 143: 15-24.
3. Lazar V, Bidart JM, Caillou B, Mahé C, Lacroix L, Fletti S, Schlumberger M. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid specific genes. J Clin Endocrinol Metab 1999; 84: 3228-34.
4. Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, Aust G, Köhrle J, Dralle H. Regulation of CD97 protein in thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 1104-9.
5. Shen WI, Chung WY. Treatment of thyroid cancer with histone deacetylase inhibitor and peroxisome proliferater-activated receptor-γ agonists. Thyroid 2005; 15: 594-9.
6. Zarnegar R, Brunaud L, Kanauchi H, Wong M, Fung M, Ginzinger D, Duh QA, Clark OH. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor. Surgery 2002; 132: 984-90.
7. Park JC, Ryu DH, Park JW, Clark OH. Redifferentiation effects of troglitazone in human thyroid cancer cell lines. J Korean Surg Soc 2004; 67: 93-9.
8. Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 2004; 25: 661-70.
9. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee TS, Lee SJ. Induction of cell cycle arrest and apotosis in human breast cancer cells by quercetin. Int J Oncol 2001; 19: 837-44.
10. Lambert JD, Hong J, Yang GY, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 2005; 81(1 Suppl): 284S-91S.
11. Yin F, Giuliano AE, Van Herle AJ. Growth inhibitory effects of flavonoids in human thyroid cancer cell line. Thyroid 1999; 9: 369-76.
12. Asou H, Koshizuka K, Kyo T, Takata N, Kamada N, Koeffier HP. Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. Int J Hematol 2002; 75: 528-33.
13. Dihal AA, Woutersen RA, van Ommen B, Rietjens IM, Stierum RH. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 2006; 238: 248-59.
14. Nakamura Y, Chang CC, Mori T, Sato K, Ohtsuki K, Upham BL, Trosko JE. Augmentation of diffentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis 2005; 26: 665-71.
15. Alonso A, Breuer B, Steuer B, Fisher J. The F9-EC line as a model for the analysis of differentiation. Int J Dev Biol 1991; 35: 389-97.
16. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397-421.
17. Gulati N, Laudet B, Zohravian VM, Murali R, Jhanwa-Uniyal M. The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res 2006; 26: 1177-81.
18. Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS. Ellagic acid potentiates the effect of quercerin on p21waf1/cip1, p53, and MAP-kinase without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 2005; 135: 609-14.
19. Ramos S. Effect of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007; 18: 427-42.
20. Folman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 1966; 34: 215-25.
21. Harris DM, Besselink E, Henning SM, Go VL, Heber D. Phytoestrogens induce differential estrogen receptor alph- or beta mediated response in transfected breast cancer cells. Exp Biol Med (Maywood) 2005; 230: 558-68.
22. Venkataraman GM, Yatin M, Marcinek R, Ain KB. Restoration of iodine uptake in dedifferentiated thyroid carcinoma: relatioship to human Na+/ I- symporter gene methylation status. J Clin Endocrinol Metab 1999; 84: 2449-57.
23. Das PM, Singal R. DNA methyation and cancer. J Clin Oncol 2004; 22: 4632-42.
24. Lee WJ, Shim JY, Zhu BT. Mechanism for the inhibiton of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005; 68: 1018-30.
25. Fang MZ, Wang Y, Ai N, Hou AZ, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Can cer Res 2003; 63: 7563-70.
26. Ulrich S, Loitsch SM, Rau O, von Knethen A, Brüne B, Schubert-Zsilavecz M, Stein JM. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 2006; 66: 7348-54.
27. Schmutzler C, Köehrle J. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 2000; 10: 393-406.
28. Elisei R, Vivaldi A, Agate L, Ciampi R, Monlinaro E, Piampiani P, Romei C, Favaiana P, Basolo F, Miccoli P, Capodano A, Collecchi P, Pacini F, Pinchera A. All-trans-Retinoic acid treatment inhibits the growth of retinoic acid receptor β messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J Clin Endocrinol Metab 2005; 90: 2403-11.
29. Hoque MO, Rosenbaum E, Westra WH, Xing M, Ladenson P, Zeiger MA, Sidransky D, Umbricht CB. Quantitative assessment of promoter methylation profiles in thyroid neoplasm. J Clin Endocrinol Metab 2005; 90: 4011-8.
30. Gardner CD, Jenny B, Liu JP, Feldman D, Franke AA, Brooks JD. Prostate soy isoflavone concentrations exceed serum levels after dietary supplementation. Prostate 2009; 69: 719-26.